President, Gregg L. Mayer & Co., Inc.
Education
BA – Biology, University of California at Berkeley
PhD – Physiology, University of California at Berkeley
Japanese Language Program, Keio University in Japan
Research Student, Keio University Graduate School of Business Administration and The National Children’s Hospital Research Center in Tokyo
Business/Research Background
Dr. Mayer was a Co-Founder and President of Berkeley Antibody Company, Inc. in Berkeley, California. He then joined Vivigen, Inc., a Nasdaq listed clinical genetic testing company in Santa Fe, New Mexico, as Director, then Vice President, and finally President. In 1988 and 1989, Vivigen was named one of “The Best Small Growth Companies in America” by Business Week magazine and was later acquired by Genzyme Corporation and subsequently Labcorp. He lived and studied in Japan with his family from 1990-1992. In 1993, Dr. Mayer joined the healthcare practice at McKinsey & Company in San Francisco. Dr. Mayer is currently President of Gregg L. Mayer & Company, Inc., a small consulting firm in El Cerrito, California. His practice specializes in helping US and EU healthcare companies develop their products in Japan and Japanese companies with their business in the US. He has worked with and advised more than 40 US, EU, and Japanese healthcare companies since 1995, helping a number of US companies open their Japanese subsidiaries. From 2021-2024 he served as an outside member of the Board of Directors of Tokyo Stock Exchange listed CMIC Holdings, Co. Ltd, the largest clinical research organization (CRO) in Japan. He was a founding director of the Disease Management Association of Japan and a board member of the Asia Pacific Society for Health Support Science. He has served as a Director of Rainforest Innovations since inception.
Particular Knowledge and Skills
Dr. Mayer’s areas of expertise are in biopharmaceutical development, healthcare services management, international technology transfer, and new venture formation in the pharmaceutical, biotechnology, medical-device, and managed-care industries in the U.S. and Japan. He lectures globally about healthcare, in both English and Japanese.